1,2-dihydronaphthalene has been researched along with Benign Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaplin, DJ; Chen, Z; Devkota, L; Guddneppanavar, R; Hamel, E; Jelinek, CJ; Lin, CM; Liu, L; Lopez, R; Mason, RP; Pinney, KG; Strecker, TE; Tidmore, JK; Trawick, ML; Wang, Y | 1 |
1 other study(ies) available for 1,2-dihydronaphthalene and Benign Neoplasms
Article | Year |
---|---|
Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
Topics: Amino Acids; Animals; Antineoplastic Agents; Bibenzyls; Breast; Breast Neoplasms; Cell Line, Tumor; Coumarins; Drug Design; Female; Humans; Mice; Mice, SCID; Naphthalenes; Neoplasms; Optical Imaging; Prodrugs; Solubility; Structure-Activity Relationship; Tubulin; Water | 2016 |